Kyle Serikawa works as a Senior Research Scientist in Genomics for Novo Nordisk. He is a recent graduate and current board member for Leadership Tomorrow in Seattle. After getting his undergraduate degree at Carleton College in Minnesota, Kyle realized he only likes snow in short, controlled bursts and moved to Berkeley for his PhD in Genetics and then the University of Washington for his postdoctoral work, where he studied algal morphology of all things. In addition to his academic work, he has had the opportunity to work for Rosetta Inpharmatics and now Novo Nordisk, where he tries to open experimental possibilities in drug development via investigating and implementing new technologies.
Consider a candidate. Selecting that candidate takes thousands of hours of time and research–checking background, verifying data, assessing probabilities, projecting futures. Once selected, more years of development follow, during which time... Read more »